The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/12766921

Download in:

View as

General Info

PMID
12766921